Literature DB >> 9196936

Complement-induced retinal arteriolar occlusions in the cat.

J C Lai1, M W Johnson, C L Martonyi, G O Till.   

Abstract

PURPOSE: To develop an animal model of complement-induced retinal vasculopathy and determine whether it resembles Purtscher's retinopathy.
METHODS: Intravenous cobra venom factor was used to achieve intravascular activation of the complement system in cats. After a single bolus of cobra venom factor (75 units/kg), retinal blood flow was monitored at regular intervals by fluorescein angioscopy and angiography.
RESULTS: Multiple small retinal arteriolar occlusions were present during the initial fluorescein transit of the immediate postinjection fluorescein study in 12 of 12 animals. Small, rapidly moving gaps in the fluorescein column were seen in two thirds of the animals observed continuously by fluorescein angioscopy. Angiographically, the obstructions were transient, and filling of the associated patches of capillary nonperfusion occurred within 3 minutes. Purtscher's-like ischemic retinal infarcts did not develop in any eye. Histopathologic analysis failed to demonstrate the nature of the transient vascular obstructive lesions, but indirect evidence suggested the possibility of granulocyte aggregates.
CONCLUSION: Intravascular activation of the complement system produces transient microembolic retinal arteriolar occlusions in the cat. Although this model may represent a mild form of Purtscher's retinopathy, factors in addition to complement activation appear necessary to induce ischemic retinal infarcts.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9196936     DOI: 10.1097/00006982-199705000-00011

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  3 in total

1.  Parafoveal arteriolar obstruction after ocular trauma in a patient with systemic lupus erithematosus.

Authors:  R N Vianna
Journal:  Int Ophthalmol       Date:  1999       Impact factor: 2.031

2.  Bilateral simultaneous central retinal artery occlusion following head injury.

Authors:  Subina Narang; Suman Kochhar; Sonika Gupta; Hemlata Gupta; Rakesh Bansal; Sunandan Sood
Journal:  Int Ophthalmol       Date:  2007-08-09       Impact factor: 2.031

3.  Reversal of threatening blindness after initiation of eculizumab in Purtscher-like retinopathy secondary to atypical hemolytic uremic syndrome.

Authors:  J E Ramos de Carvalho; R O Schlingemann; M Oranje; F J Bemelman; M J van Schooneveld
Journal:  Int Ophthalmol       Date:  2017-03-08       Impact factor: 2.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.